The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.

Cancer is a distraction and not always a bad one. We do learn perspective. There are some good things we can take away in ...

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.

Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.

Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and ...

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ...

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...

Through it all, I’ve come to realize that “Man in the Mirror” wasn’t just a song — it was a challenge. A call to action. And ...

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following ...